Géza Jakab

Company: Ceva Sante Animale

Job title: Head of Vaccine Formulation & Adjuvant Platform

Seminars:

Optimising mRNA-LNP Drug Product Stability: Enhancing Quality & Reducing Aggregation for Clinical Readiness 10:00 am

How can lyophilisation techniques be refined to preserve mRNA-LNP integrity and quality, ensuring regulatory compliance and extended shelf life? What role do nebulising agents play in reducing LNP aggregation post-formulation, and how can this improve stability for regulatory readiness? How can lipid composition and excipient selection be tailored to minimise particle size variability and maximise…Read more

day: Day Two

Fireside Chat: Addressing Formulation Challenges in Multivalent mRNA Vaccines: Ensuring Stability & Differentiation Across Strains 11:30 am

How can formulation strategies ensure the compatibility and stability of multiple, highly similar mRNA sequences in a multivalent vaccine, minimising risks of degradation or loss of functionality? What role do advanced analytical techniques play in distinguishing and monitoring the stability of individual mRNA sequences with minimal differences, ensuring consistent quality across all components? How can…Read more

day: Day Two